NASDAQ:AMPH
Amphastar Pharmaceuticals Stock News
$42.43
+0.220 (+0.521%)
At Close: May 09, 2024
Needham Remains a Buy on KalVista Pharmaceuticals (KALV)
05:10pm, Tuesday, 07'th Apr 2020
Needham analyst Serge Belanger maintained a Buy rating on KalVista Pharmaceuticals (KALV – Research Report) today and set a price
We Wouldn’t Rely On Amphastar Pharmaceuticals’s (NASDAQ:AMPH) Statutory Earnings As A Guide
10:41am, Tuesday, 07'th Apr 2020
Many investors consider it preferable to invest in profitable companies over unprofitable ones, because profitability...
Head-To-Head Analysis: Amphastar Pharmaceuticals (NASDAQ:AMPH) and Neurotrope (NASDAQ:NTRP)
06:02am, Tuesday, 07'th Apr 2020
Amphastar Pharmaceuticals (NASDAQ:AMPH) and Neurotrope (NASDAQ:NTRP) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of
Needham Thinks GW Pharma's Stock is Going to Recover
05:17pm, Monday, 06'th Apr 2020
In a report released today, Serge Belanger from Needham maintained a Buy rating on GW Pharma (GWPH), with a price target of $190.00. The company's shares
Needham Thinks GW Pharma’s Stock is Going to Recover
05:17pm, Monday, 06'th Apr 2020
In a report released today, Serge Belanger from Needham maintained a Buy rating on GW Pharma (GWPH – Research Report),
$81.66 Million in Sales Expected for Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) This Quarter
06:46am, Saturday, 04'th Apr 2020
Wall Street analysts forecast that Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) will report sales of $81.66 million for the current fiscal quarter, Zacks reports. Three analysts have provided estimates
Needham Thinks Aerie Pharma's Stock is Going to Recover
01:16pm, Friday, 03'rd Apr 2020
Needham analyst Serge Belanger maintained a Buy rating on Aerie Pharma (AERI) today and set a price target of $40.00. The company's shares closed last
Needham Thinks Aerie Pharma’s Stock is Going to Recover
01:16pm, Friday, 03'rd Apr 2020
Needham analyst Serge Belanger maintained a Buy rating on Aerie Pharma (AERI – Research Report) today and set a price
Collegium Pharmaceutical (COLL) Receives a Buy from Needham
12:56pm, Friday, 03'rd Apr 2020
Needham analyst Serge Belanger maintained a Buy rating on Collegium Pharmaceutical (COLL) today and set a price target of $38.00. The company's shares
Collegium Pharmaceutical (COLL) Receives a Buy from Needham
12:56pm, Friday, 03'rd Apr 2020
Needham analyst Serge Belanger maintained a Buy rating on Collegium Pharmaceutical (COLL – Research Report) today and set a price
Needham Thinks Flexion Therapeutics' Stock is Going to Recover
03:21pm, Wednesday, 01'st Apr 2020
In a report released today, Serge Belanger from Needham maintained a Buy rating on Flexion Therapeutics (FLXN), with a price target of $36.00. The
Needham Thinks Flexion Therapeutics’ Stock is Going to Recover
03:21pm, Wednesday, 01'st Apr 2020
In a report released today,
Serge Belanger
from Needham maintained a
Buy
rating on Flexion Therapeutics (
FLXN
–
Research Report
), with a price target of
$36.00
. The company’s shares closed last
Edited Transcript of AMPH earnings conference call or presentation 12-Mar-20 9:00pm GMT
02:56pm, Tuesday, 31'st Mar 2020
Q4 2019 Amphastar Pharmaceuticals Inc Earnings Call
Is Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) CEO Pay Justified?
12:36pm, Sunday, 29'th Mar 2020
In 1996 Jack Zhang was appointed CEO of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH). This analysis aims first to...
Edited Transcript of AMPH earnings conference call or presentation 12-Mar-20 9:00pm GMT
06:46pm, Saturday, 28'th Mar 2020
Q4 2019 Amphastar Pharmaceuticals Inc Earnings Call
